Rising Breast Cancer Incidence Fueling The Growth Of The Market Due To Increasing Demand For Early Detection: Strengthening the Growth Trajectory of the Breast Cancer Screening Test Market

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

What Is the Expected CAGR for the Breast Cancer Screening Test Market Through 2025?
The market size for breast cancer screening tests has seen solid growth in the past few years. This substantial growth will see the market size elevate from $2.31 billion in 2024 to $2.49 billion in 2025, showing a compound annual growth rate (CAGR) of 7.9%. The accelerated expansion in the past period can be credited to factors such as improved reimbursement policies, an amplified emphasis on preventive healthcare, a surge in health mindfulness, increased research and development, and heightened consciousness about early detection.

What's the Projected Size of the Global Breast Cancer Screening Test Market by 2029?
The market size of breast cancer screening tests is projected to witness robust expansion in the forthcoming years. The market is anticipated to balloon to $3.41 billion by 2029, with a compound annual growth rate (CAGR) of 8.2%. The projected growth during the forecast period can be linked to the escalating number of breast cancer cases, increased governmental interventions, expansion of healthcare spending, the growth of mobile screening units, and an increasing female populace. Key trends during this period are expected to be enhancements in imaging technology, the invention of non-invasive screening techniques, progress in genetic and genomic testing, along with the advancement of mobile screening solutions.

View the full report here:
https://www.thebusinessresearchcompany.com/report/breast-cancer-screening-test-global-market-report

Top Growth Drivers in the Breast Cancer Screening Test Industry: What's Accelerating the Market?
The surge in breast cancer rates is anticipated to boost the development of the breast cancer screening test market in the future. Uncontrolled proliferation of abnormal cells in the breast tissue, forming a tumor that may possibly metastasize to other body regions, defines breast cancer. This rise can be attributed to our globally ageing population, with increasing age being a major contributor to the disease, and longer life expectancies equating to a greater number of individuals. Breast cancer screening tests play a crucial role in early detection of the disease, thereby enhancing the likelihood of effective treatment and decreasing mortality associated with breast cancer. For example, Breastcancer.org, a nonprofit organization based in the US, revealed that around 316,950 women are projected to receive an invasive breast cancer diagnosis in March 2025, while 59,080 new non-invasive ductal carcinoma in situ (DCIS) cases could be reported. Additionally, the Public Health Agency of Canada, a governmental agency in Canada, predicts that a staggering 28,600 Canadian women are expected to be diagnosed with breast cancer in December 2024, and around 5,500 could succumb to the illness in 2022. As a result, these escalating rates of breast cancer are fuelling the expansion of the breast cancer screening test market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=24180&type=smp

What Trends Will Shape the Breast Cancer Screening Test Market Through 2029 and Beyond?
Key players in the breast cancer screening test market are driving innovation by creating novel products like mobile cancer screening units. These are aimed at amplifying accessibility, improving early diagnosis rates, and broadening screening coverage in isolated and neglected regions. A mobile cancer screening unit is a movable unit outfitted with diagnostic imaging methods such as mammography. Its purpose is to offer on-spot breast cancer screening services in remote or underserved locations. In September 2024, for instance, Granules India Ltd., a pharmaceutical firm based in India, rolled out the Breast Health Express to enhance breast cancer screening in disadvantaged communities. Outfitted with cutting-edge mammography and ultrasound technology, the unit allows for high-quality screenings whilst on the move. The primary objective of this venture is to reach overlooked rural communities with limited access to healthcare services, ensuring that even women residing in isolated regions have access to potentially life-saving early detection services.

What Are the Main Segments in the Breast Cancer Screening Test Market?
The breast cancer screening test market covered in this report is segmented -

1) By Diagnostic Test Type: Blood Marker Test, Imaging Test, Genetic Test, Immunohistochemistry Test
2) By Risk Level: High-risk Population, Moderate-risk Population, Average-risk Population
3) By End User: Hospitals, Diagnostic Centres, Cancer Institutes, Research Laboratories

Subsegments:
1) By Blood Marker Test: Circulating Tumor Cells (Ctcs) Test, Gene Expression Profiling Test, Circulating Tumor Dna (Ctdna) Test, Proteomic Biomarker Test
2) By Imaging Test: Mammography, Magnetic Resonance Imaging Screening Test, Molecular Breast Imaging Test, Positron Emission Tomograph Scan, Ultrasound
3) By Genetic Test: Fluorescence In Situ Hybridization, Her Gene Test
4) By Immunohistochemistry (Ihc) Test: Estrogen Receptor (Er) Test, Ki-67 Proliferation Marker Test, Progesterone Receptor (Pr) Test, Her2 Or Neu Test

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=24180&type=smp

Which Top Companies are Driving Growth in the Breast Cancer Screening Test Market?
Major companies operating in the breast cancer screening test market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Siemens Healthcare GmbH, Fujifilm Corporation, Koninklijke Philips NV, GE HealthCare Technologies Inc., Quest Diagnostics Incorporated, Hologic Inc., Hitachi High-Tech Corporation, Exact Sciences Corporation, Natera Inc., Myriad Genetics Inc., Canon Medical Systems Corporation, Provista Diagnostics Inc., POC Medical Systems Inc., Niramai Health Analytix Pvt. Ltd., Kheiron Medical Technologies Limited, UE LifeSciences Inc., Dxcover Limited

Which Regions Will Dominate the Breast Cancer Screening Test Market Through 2029?
North America was the largest region in the breast cancer screening test market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the breast cancer screening test market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=24180

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Saumya Sahey
Europe: +44 7882 955267,
Asia: +44 7882 955267 & +91 8897263534,
Americas: +1 310-496-7795
Email: saumyas@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.